Skip to content

Effect of Bran Fiber Type on Subjective and Objective Measures of Appetite

Effect of Bran Fiber Type on Subjective and Objective Measures of Appetite

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01560000
Enrollment
40
Registered
2012-03-21
Start date
2012-03-31
Completion date
2012-12-31
Last updated
2013-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food

Keywords

The focus of this study is to determine satiety

Brief summary

The objective of this study is to determine the satiety value of different bran fibers on appetite & subsequent food intake with acute consumption. Satiety will be measured subjectively by visual analogue scales (VAS).

Detailed description

Visual analogue scales will be used to measure satiety at 15, 30 45, 60, 120, 180, and 240 minutes

Interventions

DIETARY_SUPPLEMENTDietary fiber

Wheat, barley, oat and bran fibers added to a breakfast product

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy women between the ages of 18-40 * body mass index between 18.5-29.9kg/m2 * eat breakfast regularly * nonsmoking * not taking weight loss medications * non-dieting (weight stable over the past 3 months) * spoken and written English literacy.

Exclusion criteria

* antibiotic use within the past 6 months * cardiovascular disease * diabetes mellitus * cancer in the past 5 years * renal or hepatic disease * recent bacterial infection * gastrointestinal conditions affecting digestion or absorption * weight loss\>5kg in prior 3 months (intentional or unintentional) * history of drug or alcohol abuse in prior 6 months * food allergies * high fiber intake(3 or more servings of high fiber foods per day) * lipid-lowering, anti-hypertensive or anti-inflammatory steroid medication use * restrained eater(score\>10 on the dietary restraint factor of the Three Factor Eating Questionnaire) * concurrent or recent (within 30 days) participation in an intervention study.

Design outcomes

Primary

MeasureTime frame
Satiety response4 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026